Animal models have little to teach us about type 1 diabetes: 1. In support of this proposal.
about
Insulitis in human type 1 diabetes: a comparison between patients and animal modelsThe microbiology of human hygiene and its impact on type 1 diabetesOpinion: Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetesGenome annotation for clinical genomic diagnostics: strengths and weaknessesUse of nonobese diabetic mice to understand human type 1 diabetesEvaluating preclinical efficacy.Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice.Type 1, type 1.5, and type 2 diabetes: NOD the diabetes we thought it wasThe role of the intestinal microbiota in type 1 diabetes mellitus.Tissue-Specific Stem Cells Obtained by Reprogramming of Non-Obese Diabetic (NOD) Mouse-Derived Pancreatic Cells Confer Insulin Production in Response to Glucose.Treatment of severe autoimmune disease by stem-cell transplantation.The potential for stem cell therapy in diabetes.Are insights gained from NOD mice sufficient to guide clinical translation? Another inconvenient truth.Humanized mice for the study of type 1 diabetes and beta cell functionGenetically engineered human islets protected from CD8-mediated autoimmune destruction in vivo.Establishing humanized mice using stem cells: maximizing the potential.Elimination of T cell reactivity to pancreatic β cells and partial preservation of β cell activity by peptide blockade of LFA-1:ICAM-1 interaction in the NOD mouse model.Generation of pluripotent stem cells from patients with type 1 diabetes.Animal models of catheter-induced intimal hyperplasia in type 1 and type 2 diabetes and the effects of pharmacologic intervention.Immunomodulation with heat shock protein DiaPep277 to preserve beta cell function in type 1 diabetes - an update.DiaPep277 peptide therapy in the context of other immune intervention trials in type 1 diabetes.Cellular reprogramming: a new technology frontier in pharmaceutical research.Animal models of human type 1 diabetes for evaluating combination therapies and successful translation to the patient with type 1 diabetes.Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside.Metabolically inactive insulin: friend or foe in the prevention of autoimmune diabetes?The elusive role of B lymphocytes and islet autoantibodies in (human) type 1 diabetes.Current practices and future outlook on the integration of biomarkers in the drug development process.Aetiology of type 1 diabetes: Physiological growth in children affects disease progression.An immunohistochemical study of nitrotyrosine expression in pancreatic islets of cases with increasing duration of type 1 diabetes and without diabetes.Pathogenesis of Type 1 Diabetes Mellitus and Rodent Experimental Models.Experimental Models of Spinal Cord Injury in Laboratory Rats
P2860
Q27023712-FB34F42F-E6F6-4B3E-BB0D-A15A4D54EDD8Q27026794-6BA63CD1-F858-4F41-97AE-EFF9C36B4FB1Q29393228-4ECB460D-1166-4262-A1B0-0C940939DB99Q33737782-9F8D17A0-F868-40CF-AA65-A9B247B94840Q34078163-D012916D-0399-4531-AB35-10287C8EC3D5Q34208736-B3B0AE7D-A3E3-43C0-A133-BADB3573B5DEQ34948525-D190AFFB-48B7-492B-96CE-C180BDFE1B7BQ35033592-FD0DCC01-3FA4-42B4-9B07-C35AAFEAFD80Q35884681-93745C54-DA09-48D6-96F0-2C8D8A8ACFE2Q36143021-1ED99570-0B0B-4C00-8280-2BE052EA4A65Q36148421-AF309406-04AE-42F3-A2FF-0B55D2F31920Q36426351-9518AB17-96B1-4DDB-B9FE-9F023CC969B9Q36766166-4A0ADC88-D0D5-420E-88A8-7E5606CF37F0Q37049736-7E390189-3F48-464D-9F25-B5C21EDD7AD8Q37073103-903FC275-0AF8-40AB-BE16-BBCCA58F7703Q37147232-2D2C046D-EF79-400B-9E5C-6998F02397E7Q37163580-4A43DCC4-7E58-4AAA-A1BC-6E1DA207AF2EQ37327472-B090AE2C-CC0A-444F-BAF0-ADEA26FB6275Q37367896-CE6F8CB8-9B19-4B6E-BE99-F0A4E4DF3339Q37662519-F5EA3D71-EE94-42E8-8F04-ABE636A70A79Q37900639-FE928F02-BCA1-4DC7-B03D-64AF4824FD3AQ37954112-4148350B-4AF7-4E5E-BE41-0A936DF790A3Q38660322-1D9F612B-DE64-4B21-9795-B984BACE505FQ42569246-ADDD383B-8865-4D1E-A064-31AF4F79D368Q45943982-1AE88402-884B-4D0D-B313-FB8353CC64A4Q47577827-CFBF6BCD-C4B9-4DB0-AC5C-42D3066B00DFQ47626694-8C10F9D3-3FD9-4F93-A12D-AAB156287658Q48103893-221B32F3-3B78-49B2-8032-C0CD62876FF6Q51155258-F438484A-D586-456B-A6BB-19CF8D3C1F33Q54945190-6F46997A-C6DF-4FD0-BEAA-E7A64C0F7006Q58569039-F471D673-0028-4115-A69F-BF9AE6CF7D9F
P2860
Animal models have little to teach us about type 1 diabetes: 1. In support of this proposal.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Animal models have little to t ...... . In support of this proposal.
@ast
Animal models have little to t ...... . In support of this proposal.
@en
type
label
Animal models have little to t ...... . In support of this proposal.
@ast
Animal models have little to t ...... . In support of this proposal.
@en
prefLabel
Animal models have little to t ...... . In support of this proposal.
@ast
Animal models have little to t ...... . In support of this proposal.
@en
P1433
P1476
Animal models have little to t ...... . In support of this proposal.
@en
P2093
P2888
P304
P356
10.1007/S00125-004-1517-1
P577
2004-10-13T00:00:00Z